Two Sigma Investments’s Stemline Therapeutics, Inc. STML Stock Holding History

Two Sigma Investments’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-73,852	Closed	-$702K	–	3623
2018 Q4	$702K	Sell	73,852 -42,316	-36%	-$549K	﹤0.01%	1874
2018 Q3	$1.93M	Sell	116,168 -123,429	-52%	-$1.98M	0.01%	1513
2018 Q2	$3.85M	Buy	+239,597	New	+$4.28M	0.01%	1166
2018 Q1	–	Sell	-10,873	Closed	-$170K	–	3701
2017 Q4	$170K	Buy	+10,873	New	+$145K	﹤0.01%	2952
2014 Q1	–	Sell	-35,524	Closed	-$696K	–	2379
2013 Q4	$696K	Buy	+35,524	New	+$948K	﹤0.01%	1513

Other funds holding STML

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Two Sigma Investments's STML Position: Q1 2019 in Review

Two Sigma Investments sold out of Stemline Therapeutics, Inc. (STML) in Q1 2019, closing a stake of 73,852 shares — an estimated $702K sold.

Two Sigma Investments first reported a position in STML in Q4 2013 and held it in 5 quarters. The position peaked at $3.85M in Q2 2018. 98 funds tracked by Wall St. Rank hold STML as of Q1 2019.

Two Sigma Investments reported no remaining Stemline Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
Two Sigma Investments sold 73,852 Stemline Therapeutics, Inc. shares in Q1 2019, an estimated $702K.
Two Sigma Investments first reported a position in Stemline Therapeutics, Inc. in Q4 2013 and held it in 5 quarters.
Two Sigma Investments's Stemline Therapeutics, Inc. position peaked at $3.85M in Q2 2018.
98 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q1 2019.

Based on Two Sigma Investments's 13F filing for Q1 2019, filed 15 May 2019.